Life Sciences Consulting
Camelot’s Life Sciences Consulting Practice guides pharmaceutical
and biotechnology companies across all value chain facets
from strategy to sustainable technology implementation.
Building Future-Proof Life Science Value Chains
SUPPLY CHAINs STAY IN THE SPOTLIGHT
We are witnessing a shift towards more collaborative and integrated supply chain models from CMOs towards patients. However, this shift also introduces new complexities, from navigating international regulations to managing the logistics of an increasingly fragmented supply network. Camelot’s teams of experienced life science value chain consultants are here to help you navigate these challenges with confidence.
Life Sciences Consulting
by Camelot
How We Help Clients
Navigating Product Lifecycle Management
Camelot’s life science value chain experts help you set up your processes along the whole product lifecycle from commit-to-file through to commercial launch, integrating diverse stakeholders including TechOps, Regulatory, and Quality. We aim to ensure a smooth and successful introduction of new products while also supporting phase-out.
Improving Performance with Integrated Business Planning (IBP)
It is the cross-functional end-to-end integration of planning that enables life science companies to achieve the highest service levels and supply reliability for both patients and customers at optimal inventories and minimal costs. Camelot’s life sciences consultants make sure that better planning translates into improved performance and decision-making and that all operations in a highly regulated environment including life cycle management, clinical trials, and label management are covered. Find out more about improving performance with Integrated Business Planning.
Streamlining Demand & Supply Planning
Driving Manufacturing Excellence
Enhancing Logistics & Distribution Processes
Our specialized life sciences logistics consultants offer holistic services for all facets of distribution, including developing, implementing, and optimizing pharmaceutical logistics strategies. Our expertise extends to network design and partner management, ensuring efficient operations. Additionally, we assist in the design and implementation of advanced transportation management (TM), warehouse management (WM), and visibility systems to enhance distribution processes and bolster supply chain visibility. Find out more how to elevate your Logistics Processes.
Orchestrating the Cell & Gene Therapies (CGT) Supply Chain
Working with Industry Leaders
Here is a selection of life sciences companies that have benefited from our expertise:
![](https://www.camelot-mc.com/wp-content/uploads/2024/04/c5-300x48.png)
![astra-zeneca-1-logo-black-and-white.png astra-zeneca-1-logo-black-and-white.png](https://www.camelot-mc.com/wp-content/uploads/2024/05/astra-zeneca-1-logo-black-and-white-1.png)
"Camelot supported us in bringing our new supply chain organization to life, acting as enabler and accelerator."
Andy Evans, Head of Global Supply Chain Planning, Astra Zeneca
Featured Insights
![Master Data Management for Cell and Gene Therapies](https://www.camelot-mc.com/wp-content/uploads/2024/04/Master-Data-Management-for-Cell-and-Gene-Therapies-300x200.jpg)
Master Data Management for Cell & Gene Therapies
This article presents an approach for effective data management in the rapidly advancing field of Cell & Gene Therapies.
![](https://www.camelot-mc.com/wp-content/uploads/2024/05/Biotech-Supply-Chains-300x120.jpg)
Biotech Needs to Transform Their Supply Chain Operating Model
A roadmap for biotech companies to navigate the current landscape and thrive in the face of future uncertainties
![Transforming Supply Chains in an Endemic Era](https://www.camelot-mc.com/wp-content/uploads/2024/05/Transforming-Supply-Chains-in-an-Endemic-Era-1-300x154.jpg)
Case Study: Transforming Supply Chains in an Endemic Era
How can supply chain processes be transformed from a crisis-driven planning model to one that fosters stability and continuity?
![Pharmaceutical Supply Chain](https://www.camelot-mc.com/wp-content/uploads/2024/06/Pharmaceutical-Supply-Chain-300x158.jpg)
Winds of Change in the Current Pharmaceutical Supply Chain Model
Key Challenges and Attempts Towards Resilience